Literature DB >> 10464302

Association of the Ras to mitogen-activated protein kinase signal transduction pathway with microfilaments. Evidence for a p185(neu)-containing cell surface signal transduction particle linking the mitogenic pathway to a membrane-microfilament association site.

C A Carraway1, M E Carvajal, K L Carraway.   

Abstract

Microvilli of the aggressive 13762 ascites mammary adenocarcinoma contain a large, microfilament-associated signal transduction particle whose scaffolding is a stable glycoprotein complex (Li, Y., Hua, F., Carraway, K. L., and Carraway, C. A. C. (1999) J. Biol. Chem. 274, 25651-25658) associated with the growth factor receptor p185(neu). The receptor is constitutively tyrosine-phosphorylated in the cells and microvilli, predicting that it should recruit mitogenic pathway components to this membrane-microfilament interaction site. Immunoprecipitation of cell lysates with anti-phosphotyrosine and immunoblotting showed phosphorylated forms of the mitogenic pathway proteins Shc and MAPK in addition to p185(neu), suggesting that the Ras to MAPK mitogenic pathway is activated. Immunoblotting of p185(neu)-containing microvillar fractions revealed the presence in each of stably associated Shc, Grb-2, Sos, Ras, Raf, mitogen-activated protein kinase kinase, and mitogen-activated protein kinase/extracellular signal-regulated kinase, as well as the transcription factor-phosphorylating kinase Rsk. All of these pathway components co-immunoprecipitated with p185(neu) from cleared lysates of microvilli solubilized under microfilament-depolymerizing conditions. The recruitment of constitutively phosphorylated p185(neu) and the activated mitogenic pathway proteins to this membrane-microfilament interaction site provides a physical model for integrating the assembly of the mitogenic pathway with the transmission of growth factor signal to the cytoskeleton. This linkage is probably a requisite step in the global cytoskeleton remodeling accompanying mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464302     DOI: 10.1074/jbc.274.36.25659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Authors:  Victoria P Ramsauer; Vanessa Pino; Amjad Farooq; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

2.  Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.

Authors:  Véronique Orian-Rousseau; Helen Morrison; Alexandra Matzke; Thor Kastilan; Giuseppina Pace; Peter Herrlich; Helmut Ponta
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

Review 3.  Muc4/sialomucin complex in the mammary gland and breast cancer.

Authors:  K L Carraway; S A Price-Schiavi; M Komatsu; S Jepson; A Perez; C A Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

4.  Ribosomal S6 kinase as a mediator of keratinocyte growth factor-induced activation of Akt in epithelial cells.

Authors:  Zhong-Zong Pan; Yvan Devaux; Prabir Ray
Journal:  Mol Biol Cell       Date:  2004-04-23       Impact factor: 4.138

5.  Activation of endogenous thrombin receptors causes clustering and sensitization of epidermal growth factor receptors of swiss 3T3 cells without transactivation.

Authors:  M F Crouch; D A Davy; F S Willard; L A Berven
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

6.  Dasatinib inhibits primary melanoma cell proliferation through morphology-dependent disruption of Src-ERK signaling.

Authors:  Jianghong Wu; Xin Liao; Bo Yu; Bing Su
Journal:  Oncol Lett       Date:  2012-12-10       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.